journal article·2020-01-28Open access

Multimodal Multiplexed Immunoimaging with Nanostars to Detect Multiple Immunomarkers and Monitor Response to Immunotherapies

Yu-Chuan Ou, Xiaona Wen, Christopher A. Johnson, Daniel Shae, Oscar D. Ayala, Joseph A. Webb, Eugene C. Lin, Rossane C. DeLapp, Kelli L. Boyd, Ann Richmond, Anita Mahadevan-Jansen, Marjan Rafat, John T. Wilson, Justin M. Balko, Mohammed N. Tantawy, Anna E. Vilgelm, Rizia Bardhan

ACS Nano· Volume 14· Issue 1

Abstract

The overexpression of immunomarker programmed cell death protein 1 (PD-1) and engagement of PD-1 to its ligand, PD-L1, are involved in the functional impairment of cluster of differentiation 8+ (CD8+) T cells, contributing to cancer progression. However, heterogeneities in PD-L1 expression and variabilities in biopsy-based assays render current approaches inaccurate in predicting PD-L1 status. Therefore, PD-L1 screening alone is not predictive of patient response to treatment, which motivates us to simultaneously detect multiple immunomarkers engaged in immune modulation. Here, we have developed multimodal probes, immunoactive gold nanostars (IGNs), that accurately detect PD-L1+ tumor cells and CD8+ T cells simultaneously in vivo, surpassing the limitations of current immunoimaging techniques. IGNs integrate the whole-body imaging of positron emission tomography with high sensitivity and multiplexing of Raman spectroscopy, enabling the dynamic tracking of both immunomarkers. IGNs also monitor response to immunotherapies in mice treated with combinatorial PD-L1 and CD137 agonists and distinguish responders from those nonresponsive to treatment. Our results showed a multifunctional nanoscale probe with capabilities that cannot be achieved with either modality alone, allowing multiplexed immunologic tumor profiling critical for predicting early response to immunotherapies.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Advanced biosensing and bioanalysis techniques · Biosensors and Analytical Detection · Gold and Silver Nanoparticles Synthesis and Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Chemical and Biomolecular Engineering, Vanderbilt University, Nashville, Tennessee 37235, United States

Department of Veterans Affairs, Tennessee Valley Healthcare System, Nashville, Tennessee 37212, United States

Department of Pharmacology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232, United States

Department of Biomedical Engineering, Vanderbilt University, Nashville, Tennessee 37235, United States

Radiology and Radiological Sciences, Vanderbilt University School of Medicine, Nashville, Tennessee 37232, United States

Vanderbilt University Institute of Imaging Science, Vanderbilt University School of Medicine, Nashville, Tennessee 37232, United States

Department of Chemistry and Biochemistry, National Chung Cheng University, Chiayi 62106, Taiwan

Civil and Environmental Engineering, Vanderbilt University, Nashville, Tennessee 37235, United States

Department of Pathology, Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232, United States

Department of Radiation Oncology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232, United States

Vanderbilt Center for Immunobiology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232, United States

Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee 37232, United States

Department of Pathology, Ohio State University, Columbus, Ohio 43210, United States

Department of Chemical and Biological Engineering, Iowa State University, Ames, Iowa 50012, United States

Funding

National Center for Advancing Translational Sciences · Vanderbilt University · Vanderbilt-Ingram Cancer Center · National Cancer Institute · Harry J. Lloyd Charitable Trust · Army Research Office · Air Force Office of Scientific Research · Stand Up To Cancer · Office of Naval Research · Breast Cancer Research Foundation · American Cancer Society · Division of Civil, Mechanical and Manufacturing Innovation · Division of Chemical, Bioengineering, Environmental, and Transport Systems · Melanoma Research Alliance · Congressionally Directed Medical Research Programs

References (66)

Show source-provided references
1. 10.1007/s11912-017-0627-010.1007/s11912-017-0627-0 ↗
2. 10.1038/nature1395410.1038/nature13954 ↗
3. 10.1158/1078-0432.CCR-16-256910.1158/1078-0432.CCR-16-2569 ↗
4. 10.1038/bjc.2017.43410.1038/bjc.2017.434 ↗
5. 10.1038/s41467-018-06890-y10.1038/s41467-018-06890-y ↗
6. 10.1038/s41416-019-0449-y10.1038/s41416-019-0449-y ↗
7. 10.1038/modpathol.2016.21310.1038/modpathol.2016.213 ↗
8. 10.1038/nrclinonc.2017.8810.1038/nrclinonc.2017.88 ↗
9. 10.7150/thno.2476210.7150/thno.24762 ↗
10. 10.1038/s41416-018-0220-910.1038/s41416-018-0220-9 ↗
11. 10.1073/pnas.061153310410.1073/pnas.0611533104 ↗
12. 10.1038/nature2207910.1038/nature22079 ↗
13. 10.1158/2326-6066.CIR-16-006010.1158/2326-6066.CIR-16-0060 ↗
14. 10.1038/s41551-019-0375-610.1038/s41551-019-0375-6 ↗
15. 10.1136/esmoopen-2016-00015010.1136/esmoopen-2016-000150 ↗
16. 10.1038/s41523-018-0095-110.1038/s41523-018-0095-1 ↗
17. 10.1038/natrevmats.2016.2110.1038/natrevmats.2016.21 ↗
18. 10.1016/j.tibtech.2019.11.00110.1016/j.tibtech.2019.11.001 ↗
19. 10.1039/C4TC01634C10.1039/C4TC01634C ↗
20. 10.1039/C8NR01478G10.1039/C8NR01478G ↗
21. 10.1158/2159-8290.CD-16-057710.1158/2159-8290.CD-16-0577 ↗
22. 10.1158/1078-0432.CCR-15-026310.1158/1078-0432.CCR-15-0263 ↗
23. 10.1021/acsomega.6b0007910.1021/acsomega.6b00079 ↗
24. 10.1021/jp408793a10.1021/jp408793a ↗
25. 10.2967/jnumed.112.11861210.2967/jnumed.112.118612 ↗
26. 10.2967/jnumed.117.19388810.2967/jnumed.117.193888 ↗
27. 10.7150/thno.1295610.7150/thno.12956 ↗
28. 10.1021/acsomega.7b0052710.1021/acsomega.7b00527 ↗
29. 10.1038/s41467-018-06730-z10.1038/s41467-018-06730-z ↗
30. 10.1016/S0142-9612(01)00374-X10.1016/S0142-9612(01)00374-X ↗
31. 10.1080/1061186080258246710.1080/10611860802582467 ↗
32. 10.1088/0143-0815/12/4/00510.1088/0143-0815/12/4/005 ↗
33. 10.2147/NDT.S7818210.2147/NDT.S78182 ↗
34. 10.1038/nphoton.2014.16610.1038/nphoton.2014.166 ↗
35. 10.1038/s41598-017-09116-110.1038/s41598-017-09116-1 ↗
36. 10.7150/thno.1197410.7150/thno.11974 ↗
37. 10.1111/pcmr.1249810.1111/pcmr.12498 ↗
38. 10.1038/s41598-017-03015-110.1038/s41598-017-03015-1 ↗
39. 10.1038/nmat471810.1038/nmat4718 ↗
40. 10.1038/natrevmats.2017.1410.1038/natrevmats.2017.14 ↗
41. 10.1038/s41591-018-0255-810.1038/s41591-018-0255-8 ↗
42. 10.1158/0008-5472.CAN-15-170710.1158/0008-5472.CAN-15-1707 ↗
43. 10.1038/s41598-017-02691-310.1038/s41598-017-02691-3 ↗
44. 10.1158/1078-0432.CCR-04-108410.1158/1078-0432.CCR-04-1084 ↗
45. Sato Y. · J. Nucl. Med. · 2013 · 54 · 152610.2967/jnumed.112.114355 ↗
46. 10.1038/bjc.2014.61010.1038/bjc.2014.610 ↗
47. 10.1089/cbr.2007.044410.1089/cbr.2007.0444 ↗
48. 10.7150/thno.1525310.7150/thno.15253 ↗
49. 10.1158/1078-0432.CCR-16-319310.1158/1078-0432.CCR-16-3193 ↗
50. 10.1002/lsm.2065310.1002/lsm.20653 ↗
51. 10.1080/0570492070155153010.1080/05704920701551530 ↗
52. 10.1038/natrevmats.2016.1410.1038/natrevmats.2016.14 ↗
53. 10.1158/2326-6066.CIR-15-016010.1158/2326-6066.CIR-15-0160 ↗
54. 10.1038/s41571-019-0169-510.1038/s41571-019-0169-5 ↗
55. 10.1038/modpathol.2017.10410.1038/modpathol.2017.104 ↗
56. 10.2147/OTT.S11712110.2147/OTT.S117121 ↗
57. 10.1073/pnas.190692911610.1073/pnas.1906929116 ↗
58. 10.1364/OL.30.00050710.1364/OL.30.000507 ↗
59. 10.1371/journal.pone.021631110.1371/journal.pone.0216311 ↗
60. 10.1126/scitranslmed.aaa238410.1126/scitranslmed.aaa2384 ↗
61. 10.1021/acsnano.5b0720010.1021/acsnano.5b07200 ↗
62. 10.1038/lsa.2017.8210.1038/lsa.2017.82 ↗
63. 10.1016/j.neuron.2014.04.04110.1016/j.neuron.2014.04.041 ↗
64. 10.1038/nprot.2017.03110.1038/nprot.2017.031 ↗
65. 10.1038/s41570-017-006010.1038/s41570-017-0060 ↗
66. 10.1038/nmeth.201910.1038/nmeth.2019 ↗